Artugen Therapeutics Ltd.

Laurent Chesnel

Paul Ross

Colin Hill

Ronald Farquhar

Mary Rea

Michelle O'Donnell

Brian Healy

Christopher K Murphy

Disclosed herein are compositions and methods for preventing, ameliorating, or treatinginfections and/or reducing the severity of one or more risk factors, signs, or symptoms associated withinfections. In particular, the technology of the present disclosure relates to methods for administering an effective amount of a composition comprising strains ofbacteria identified as ART24, ART4, and ART 12, to a subject suffering from or at risk forinfections.

Methods and compositions for the treatment of C. difficile

Disclosed herein are compositions and methods for preventing, ameliorating, or treatinginfections and/or reducing the severity of one or more risk factors, signs, or symptoms associated withbacteria identified as ART24, ART4, and ART 12, to a subject suffering from or at risk forinfections.

Growing community of inventors

Bedford, MA, United States of America

Laurent Chesnel